Page 540 - Clinical Hematology_ Theory _ Procedures ( PDFDrive )

524 PART 7 ■ Principles and Disorders of Hemostasis and Thrombosis

REVIEW QUESTIONS

*Indicates ML (optional) and MLS advanced content. *6. Drug-in uce ate et ys unction can be cause by

1. Which o the o owing is a con ition associate with A. As irin

ur ura? B. von Wi ebran ’s isease

A. Direct en othe ia a age C. Ure ia

B. Inherite isease o the connective tissue D. Factor V e ciency

C. Mechanica isru tion o s a venu es

D. A o the above *7. Here itary ate et ys unction can be cause by

A. As irin

2. Wiskott-A rich syn ro e is characterize by B. von Wi ebran ’s isease

A. Giant ate ets C. Ure ia

B. S a est ate ets seen D. Factor V e ciency

C. Large ate ets

D. Absence o ate ets *8. An exa e o an agent that oes not ro uce signi -

cant y ecrease ri ary ate et aggregation in atients

3. May-Hegg in ano a y is characterize by su ering ro G anz ann’s thro basthenia is

A. Giant ate ets A. Co agen

B. S a est ate ets seen B. Ristocetin

C. Large ate ets C. ADP

D. Absence o ate ets D. T ro bin

4. Bernar -Sou ier syn ro e is characterize by *9. When co aring von Wi ebran ’s isease an

A. Giant ate ets G anz ann’s thro basthenia, G anz ann’s thro bas-

B. S a est ate ets seen thenia wi e onstrate

C. Large ate ets A. Absent ADP

D. Absence o ate ets B. Nor a c ot retraction

C. Abnor a ristocetin aggregation

*5. Acquire ate et ys unction can be cause by D. Abnor a re ease o ADP

A. As irin

B. von Wi ebran ’s isease

C. Ure ia

D. Factor V e ciency

Arno DM. B ee ing co ications in i une thro bocyto enia,
COMPANION RES OURCES American Society o Hematology Annual Meeting Educational Book,

Or an o, FL, Dece ber 2015.
htt ://the oint. ww.co / urgeon6e
Aster RH, Bougie DW. Drug in uce i une thro bocyto enia,

Each stu ent is encourage to access an use the web- N Engl Med, 357(6):580–587, 2007.

base co anion resources eve o e or this cha ter. Bates SM, Ginsberg JS. reat ent o ee -vein thro bosis, N Engl

Here you wi n a itiona earning too s to increase Med, 351(3):268–277, 2004.

your un erstan ing o the conce ts an c inica a ica- Bro berg ME. I une thro bocyto enic ur ura-the changing ther-
a eutic an sca e, N Engl Med, 355(16):1643–1645, 2006.
tions o the cha ter.
Can e P, Perotta PL. Recognizing HI , Adv Lab, 16(2):42–43, 2007.

Cazzo a M. Mo ecu ar basis o thro bocytosis, Haematologica,

93(5):646–648, 2008.
BIBLIOGRAPHY Dah bäck B. A vances in un erstan ing athogenic echanis s o

thro bo hi ic isor ers, Blood, 112(1):19–27, 2008.

A cock DM. Is there a genetic re ationshi between arteria an Dryga ski AV, et a . Vanco ycin-in uce i une thro bocyto enia,

venous thro bosis? Clin Lab Sci, 20(4):221–223, 2007. N Engl Med, 356(9):904–910, 2007.

Aga itov AV, Haynes WG. Ro e o en othe in in car iovascu ar is- George JN, et a . Chronic i io athic thro bocyto enic ur ura, N Engl
ease, J Renin Angiotensin Aldosterone Syst, 3(1):1–15, 2002. J Med, 331(18):1207–1215, 1994.

A thaus K, Greinacher A. MYH9-re ate ate et isor ers, Semin Greer JP, et a . Clinical Hematology, 13th e , Phi a e hia, PA: Li incott

Tromb Hemost, 35:189–203, 2009. Wi ia s & Wi kins, 2014.

Are a y GM, Orte L. He arin-in uce thro bocyto enia, N Engl Greer JP, et a . Clinical Hematology, 14th e , Phi a e hia, PA: Li incott
Med, 355(8):809–817, 2006. Wi ia s & Wi kins, 2016.